Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits - PubMed (original) (raw)

. 1991 Dec 20;254(5039):1802-5.

doi: 10.1126/science.1722351.

Affiliations

• PMID: 1722351
• DOI: 10.1126/science.1722351

Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits

J R Chowdhury et al. Science. 1991.

Abstract

Familial hypercholesterolemia (FH) is an inherited disorder in humans that is caused by a deficiency of low density lipoprotein receptors (LDLRs). An animal model for FH, the Watanabe Heritable Hyperlipidemic rabbit, was used to develop an approach for liver-directed gene therapy based on transplantation of autologous hepatocytes that were genetically corrected ex vivo with recombinant retroviruses. Animals transplanted with LDLR-transduced autologous hepatocytes demonstrated a 30 to 50 percent decrease in total serum cholesterol that persisted for the duration of the experiment (122 days). Recombinant-derived LDLR RNA was harvested from tissues with no diminution for up to 6.5 months after transplantation.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal